HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drunk Elephant Hit With Sobering Allegations Of Fraudulent Medical Claims

This article was originally published in The Rose Sheet

Executive Summary

A plaintiff in New York’s Southern District says Drunk Elephant’s claims about skin firming and other benefits, used to promote its $60 Shaba Complex Eye Serum, either are bogus or identify the product as an unapproved drug. A similar case against Beiersdorf/NIVEA is currently under appeal in California.

You may also be interested in...



Appeals Court To Hear Suit Alleging Nivea Lotion Is Unlawfully Marketed Drug

Beiersdorf's Nivea Skin Firming Hydration Body Lotion is an unapproved drug based on the brand's skin-tightening claims, according to a plaintiff who says she should not have spent money on a product that is on the market illegally. A California district court dismissed the suit April 4, but the plaintiff is appealing.

Beiersdorf Moves To Squash Suit Alleging NIVEA Firming Lotion Is An Unapproved Drug

Plaintiff claims that she and other Californians purchased a NIVEA skin-firming lotion “that, but for Defendant’s illegal conduct, would not have been on the market” due to its alleged unapproved drug status. This is her second amended complaint against Beiersdorf, the first having been dismissed in August 2015.

Avon Beats Class Bid In Suit Challenging Anti-Aging Claims; Appeal Filed

A New York district court has denied class certification in a suit targeting Avon ANEW wrinkle and collagen claims that plaintiffs say were deceptive and misleading. Claims at issue mainly appeared in brochures distributed sporadically by independent sales reps, but they also were featured on Avon's website, with the district judge ruling it infeasible to determine whether all class members were harmed by the statements.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121548

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel